Aktiesnakken — Oktober 2018
-
Off label: Der var jo Jefferies "US MM Proprietary Physician Survey" her fornylig, hvor de rundspurgte 50 læger: Encouraging uptake in 1st line setting despite data for key combination pending: Around 60% of physicians report using Darzalex, either alone or in combination. If accurate, our survey suggests a fairly rapid adoption 1st line, and likely off-label use in the +Rd setting, in our view.
-
Det er rent blodbad..
-
Uhyggeligt at tænke på hvor det ender???
-
-
Godmorgen aktie-folkens
-
-
God morgen.
-
Godmorgen folkens
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind